369 related articles for article (PubMed ID: 8106159)
1. Pharmacodynamic profile of carvedilol.
van Zwieten PA
Cardiology; 1993; 82 Suppl 3():19-23. PubMed ID: 8106159
[TBL] [Abstract][Full Text] [Related]
2. An overview of the pharmacodynamic properties and therapeutic potential of combined alpha- and beta-adrenoceptor antagonists.
van Zwieten PA
Drugs; 1993 Apr; 45(4):509-17. PubMed ID: 7684671
[TBL] [Abstract][Full Text] [Related]
3. Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol.
Nichols AJ; Gellai M; Ruffolo RR
Fundam Clin Pharmacol; 1991; 5(1):25-38. PubMed ID: 1712335
[TBL] [Abstract][Full Text] [Related]
4. Vasodilatory action of carvedilol.
Sponer G; Strein K; Bartsch W; Müller-Beckmann B
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S5-11. PubMed ID: 1378150
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure.
Ruffolo RR; Feuerstein GZ
Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():247-56. PubMed ID: 9211017
[TBL] [Abstract][Full Text] [Related]
6. Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
McTavish D; Campoli-Richards D; Sorkin EM
Drugs; 1993 Feb; 45(2):232-58. PubMed ID: 7681374
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of carvedilol in the myocardium.
Feuerstein GZ; Bril A; Ruffolo RR
Am J Cardiol; 1997 Dec; 80(11A):41L-45L. PubMed ID: 9412541
[TBL] [Abstract][Full Text] [Related]
8. The role of alpha- and beta-adrenoceptor blockade in antihypertensive treatment.
van Zwieten PA
Clin Investig; 1992; 70 Suppl 1():S7-12. PubMed ID: 1350488
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of carvedilol.
Dulin B; Abraham WT
Am J Cardiol; 2004 May; 93(9A):3B-6B. PubMed ID: 15144929
[TBL] [Abstract][Full Text] [Related]
10. In vitro pharmacologic profile of the novel beta-adrenoceptor antagonist and vasodilator, carvedilol.
Nichols AJ; Sulpizio AC; Ashton DJ; Hieble JP; Ruffolo RR
Pharmacology; 1989; 39(5):327-36. PubMed ID: 2575762
[TBL] [Abstract][Full Text] [Related]
11. Beta-adrenoceptor blockade and vasodilatation in essential hypertension. Hemodynamic studies at rest and during exposure to stress.
Eggertsen R
Acta Med Scand Suppl; 1984; 689():1-46. PubMed ID: 6151343
[TBL] [Abstract][Full Text] [Related]
12. Lack of evidence for peripheral alpha(1)- adrenoceptor blockade during long-term treatment of heart failure with carvedilol.
Kubo T; Azevedo ER; Newton GE; Parker JD; Floras JS
J Am Coll Cardiol; 2001 Nov; 38(5):1463-9. PubMed ID: 11691524
[TBL] [Abstract][Full Text] [Related]
13. Single and repeated doses of the vasodilator/beta-adrenergic antagonist, carvedilol, block cirazoline- and isoproterenol-mediated hemodynamic responses in the conscious rat.
Smith EF; Slivjak MJ; Gagnon R
Cardiovasc Drugs Ther; 1992 Oct; 6(5):499-504. PubMed ID: 1360255
[TBL] [Abstract][Full Text] [Related]
14. Carvedilol.
Frishman WH
N Engl J Med; 1998 Dec; 339(24):1759-65. PubMed ID: 9845712
[No Abstract] [Full Text] [Related]
15. Activation of capsaicin-sensitive sensory neurons by carvedilol, a nonselective beta-blocker, in spontaneous hypertensive rats.
Okajima K; Harada N; Uchiba M; Isobe H
J Pharmacol Exp Ther; 2004 May; 309(2):684-91. PubMed ID: 14764656
[TBL] [Abstract][Full Text] [Related]
16. Acute and long-term hemodynamic effects of carvedilol, a combined beta-adrenoceptor blocking and precapillary vasodilating agent, in hypertensive patients.
Eggertsen R; Sivertsson R; Andrén L; Hansson L
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S97-100. PubMed ID: 2454378
[TBL] [Abstract][Full Text] [Related]
17. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
Feuerstein GZ; Yue TL; Cheng HY; Ruffolo RR
J Hypertens Suppl; 1993 Jun; 11(4):S41-8. PubMed ID: 8104241
[TBL] [Abstract][Full Text] [Related]
18. [Balanced beta--alpha-blocker treatment with carvedilol in mild-moderate arterial hypertension].
Perocchio M; Gigli G; Barra M; Sacchetti R; Vallebona A; Rosolen GA; Orlandi S
Minerva Cardioangiol; 1996 Mar; 44(3):115-21. PubMed ID: 8767610
[TBL] [Abstract][Full Text] [Related]
19. Carvedilol: molecular and cellular basis for its multifaceted therapeutic potential.
Cheng J; Kamiya K; Kodama I
Cardiovasc Drug Rev; 2001; 19(2):152-71. PubMed ID: 11484068
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacokinetics and pharmacodynamics of carvedilol.
Morgan T
Clin Pharmacokinet; 1994 May; 26(5):335-46. PubMed ID: 7914479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
